Adjuvant chemotherapy for elderly patients with colorectal cancer: a single-center observational study in Japan
Authors:
Preprint
- 17 March 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Purpose: Adjuvant chemotherapy improves the prognosis of patients with colorectal cancer (CRC) following radical resection. The aim of the present study is to review appropriate chemotherapeutic regimens for elderly patients. Methods: We examined 1243 Japanese patients who received adjuvant therapy for high-risk stage II, III, or IV CRC between July 2010 and June 2021 at our hospital. Patients were divided according to an age of 70 years. The efficacy of adjuvant therapy was analyzed in association with age and adjuvant chemotherapeutic regimens. Results: A total of 544 patients (44%) were ≥70 years old. They were less likely to receive adjuvant chemotherapy (ppp=0.006); however, CSS by regimens did not significantly differ between these groups. Adjuvant chemotherapy was associated with the longer relapse-free survival of stage III CRC patients in the p=0.005). CSS in these patients was prolonged in both the p=0.019) and ≥70 years group (p=0.009) who received adjuvant chemotherapy.. Conclusions: Although adjuvant chemotherapy was associated with a favorable prognosis regardless of age, the implementation rate of adjuvant chemotherapy for elderly CRC patients was low, which may explain shorter CSS in stage III CRC patients the ≥70 years group than in the <70 years group. Further studies are needed to establish an optimal adjuvant regimen for elderly patients.Keywords
All Related Versions
- Version 1, 2023-03-17, Research Square
- Published version: Journal of Chemotherapy, 36 (4), 319.
This publication has 29 references indexed in Scilit:
- Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trialDigestive and Liver Disease, 2022
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancerAnnals of Oncology, 2021
- Associations between the Geriatric-8 and 4-meter gait speed test and subsequent delivery of adjuvant chemotherapy in older patients with colon cancerJournal of Geriatric Oncology, 2021
- Determinants of Variation in the Use of Adjuvant Chemotherapy for Stage III Colon Cancer in EnglandClinical Oncology, 2020
- Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancerInternational Journal of Clinical Oncology, 2019
- Influence of age and comorbidity on prognosis and application of adjuvant chemotherapy in elderly Japanese patients with colorectal cancer: A retrospective multicentre studyEuropean Journal of Cancer, 2017
- Intensity of adjuvant chemotherapy regimens and grade III–V toxicities among elderly stage III colon cancer patientsEuropean Journal of Cancer, 2016
- Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapyJournal of Geriatric Oncology, 2013
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987